Compass Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Compass Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11065
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Compass Therapeutics LLC (Compass Therapeutics) is a biotechnology company that strives to develop transformational therapies for cancer, inflammation and autoimmune diseases. The company focuses on the discovery of antibody drug candidates that involve all targets in the complex immune function in humans, with particular attention to T cells, NK cells and macrophages. Its product pipeline includes CTX-471, CTX-2026, CTX-1349, CTX-1605 and others. Compass Therapeutics develops both agonists and antagonists, which facilitate the development of monotherapies and combination therapies. It utilizes Sympleitope technology platform for epitope screening and selection; and StitchMabs, a novel multispecific antibody screening platform to combine two or more monoclonal antibodies into customized bi- and multi-specific formats. Compass Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Compass Therapeutics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Compass Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Compass Therapeutics Raises USD132 Million in Series A Financing 10
Compass Therapeutics USD22 Million in Venture Financing 12
Compass Therapeutics Raises USD16 Million in Financing 13
Kairos Biologics Raises USD0.5 Million in Venture Financing 14
Compass Therapeutics Raises USD0.5 Million in Venture Financing 15
Partnerships 16
Applied BioMath Enters into Agreement with Compass Therapeutics 16
Compass Therapeutics LLC – Key Competitors 17
Compass Therapeutics LLC – Key Employees 18
Compass Therapeutics LLC – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Key Facts 2
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Compass Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Compass Therapeutics LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Compass Therapeutics Raises USD132 Million in Series A Financing 10
Compass Therapeutics USD22 Million in Venture Financing 12
Compass Therapeutics Raises USD16 Million in Financing 13
Kairos Biologics Raises USD0.5 Million in Venture Financing 14
Compass Therapeutics Raises USD0.5 Million in Venture Financing 15
Applied BioMath Enters into Agreement with Compass Therapeutics 16
Compass Therapeutics LLC, Key Competitors 17
Compass Therapeutics LLC, Key Employees 18

List of Figures
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Compass Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Compass Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Merck & Co Inc (MRK):企業の財務・戦略的SWOT分析
    Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • PaxVax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PaxVax Inc (PaxVax) is a vaccine company that develops and commercializes specialty vaccines against infectious diseases. The company develops scalable, and oral vaccines. Its activities include early-stage preclinical research and development, clinical study support, drug product manufactur …
  • Dermira Inc (DERM)-医療機器分野:企業M&A・提携分析
    Summary Dermira Inc (Dermira) is a bio-pharmaceutical company which concentrates on the development and commercialization of novel therapies for the treatment of chronic skin conditions. The company concentrates on developing drugs for the treatment of diseases such as psoriasis, hyperhidrosis, atop …
  • Infinity Pharmaceuticals Inc (INFI):企業の財務・戦略的SWOT分析
    Infinity Pharmaceuticals Inc (INFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Helijet International Inc.:企業の戦略・SWOT・財務情報
    Helijet International Inc. - Strategy, SWOT and Corporate Finance Report Summary Helijet International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Maintel Holdings Plc (MAI):企業の財務・戦略的SWOT分析
    Summary Maintel Holdings Plc (Maintel) is a telecommunication service provider that supports voice and data equipments. The company provides collaborations, customer experience and optimization, connectivity, security and networking, mobile professional and transformation services and managed servic …
  • National Heart Lung and Blood Institute-製薬・医療分野:企業M&A・提携分析
    Summary National Heart Lung and Blood Institute (NHLBI), a subsidiary of National Institutes of Health is a medical research institute that provides treatment for heart, lung, and blood diseases.The institute conducts research studies with patients who have diseases of heart and blood vessels, lungs …
  • La Plata Electric Association, Inc.:発電所・企業SWOT分析
    La Plata Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Medanito SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Medanito SA (Medanito) is an upstream energy company. The company operates in the business of exploration and production of oil and natural gas with participation in the development of unconventional reserves. It operates in the gathering and processing of natural gas liquids (NGL); and gas- …
  • Libbey Inc (LBY):企業の財務・戦略的SWOT分析
    Libbey Inc (LBY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cintas Corporation:企業の戦略・SWOT・財務分析
    Cintas Corporation - Strategy, SWOT and Corporate Finance Report Summary Cintas Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Thales Deutschland GmbH:企業の戦略・SWOT・財務分析
    Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report Summary Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Service Corporation International (SCI):企業の財務・戦略的SWOT分析
    Service Corporation International (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Ralph Lauren Corporation:戦略・SWOT・企業財務分析
    Ralph Lauren Corporation - Strategy, SWOT and Corporate Finance Report Summary Ralph Lauren Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Alfa Laval AB (ALFA):企業の財務・戦略的SWOT分析
    Alfa Laval AB (ALFA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Galp Energia SGPS SA (GALP):石油・ガス:M&Aディール及び事業提携情報
    Summary Galp Energia SGPS SA (Galp) is an integrated energy company. It explores for, develops and produces crude oil and natural gas, refines crude oil, and markets refined petroleum products. The company also conducts power generation, produces biodiesel and trades gas. It imports, transports and …
  • Aristocrat Leisure Ltd (ALL):企業の財務・戦略的SWOT分析
    Aristocrat Leisure Ltd (ALL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Altus Group Limited:企業のM&A・事業提携・投資動向
    Altus Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Altus Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Asahi Kasei Corp (3407):製薬・医療:M&Aディール及び事業提携情報
    Summary Asahi Kasei Corp (Asahi Kasei), manufactures, and markets chemical products. The product portfolio of the company includes polymers, acrylonitrile, styrene, diagnostic reagents, foam insulation panels, foundation systems, methyl methacrylate, adipic acid, polyethylene, polystyrene, functiona …
  • KineMed Inc-製薬・医療分野:企業M&A・提携分析
    Summary KineMed Inc (KineMed) is a biotechnology company that develops and commercializes proprietary biomarker platform technology. The company applies its proprietary biomarker platform technology to drug development, prescription, and non-prescription medical diagnostics and the pairing of drugs …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆